日本ケミファの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2018/12/10 | 3,980 | 4,000 | 3,840 | 3,840 | -85 | -2.2% | 2,500 |
| 2018/12/07 | 4,060 | 4,065 | 3,925 | 3,925 | -10 | -0.3% | 4,000 |
| 2018/12/06 | 4,050 | 4,050 | 3,935 | 3,935 | -155 | -3.8% | 4,500 |
| 2018/12/05 | 4,120 | 4,120 | 4,030 | 4,090 | +40 | +1% | 4,900 |
| 2018/12/04 | 4,080 | 4,100 | 4,040 | 4,050 | -75 | -1.8% | 3,200 |
| 2018/12/03 | 4,205 | 4,205 | 4,100 | 4,125 | -10 | -0.2% | 1,700 |
| 2018/11/30 | 4,225 | 4,225 | 4,125 | 4,135 | -40 | -1% | 1,500 |
| 2018/11/29 | 4,150 | 4,190 | 4,150 | 4,175 | -20 | -0.5% | 700 |
| 2018/11/28 | 4,230 | 4,250 | 4,130 | 4,195 | -35 | -0.8% | 2,900 |
| 2018/11/27 | 4,225 | 4,230 | 4,155 | 4,230 | ±0 | ±0% | 900 |
| 2018/11/26 | 4,165 | 4,230 | 4,130 | 4,230 | +65 | +1.6% | 1,800 |
| 2018/11/22 | 4,225 | 4,225 | 4,085 | 4,165 | +80 | +2% | 1,600 |
| 2018/11/21 | 4,085 | 4,095 | 4,080 | 4,085 | ±0 | ±0% | 900 |
| 2018/11/20 | 4,085 | 4,085 | 4,085 | 4,085 | -20 | -0.5% | 500 |
| 2018/11/19 | 4,090 | 4,145 | 4,090 | 4,105 | -50 | -1.2% | 500 |
| 2018/11/16 | 4,080 | 4,195 | 4,080 | 4,155 | +100 | +2.5% | 1,300 |
| 2018/11/15 | 4,060 | 4,060 | 4,050 | 4,055 | -5 | -0.1% | 700 |
| 2018/11/14 | 4,070 | 4,095 | 4,060 | 4,060 | -10 | -0.2% | 2,100 |
| 2018/11/13 | 4,085 | 4,155 | 4,070 | 4,070 | -15 | -0.4% | 1,100 |
| 2018/11/12 | 4,075 | 4,085 | 4,070 | 4,085 | -45 | -1.1% | 1,600 |
| 2018/11/09 | 4,150 | 4,150 | 4,090 | 4,130 | -20 | -0.5% | 800 |
| 2018/11/08 | 4,160 | 4,225 | 4,145 | 4,150 | +85 | +2.1% | 2,300 |
| 2018/11/07 | 4,155 | 4,155 | 4,065 | 4,065 | -100 | -2.4% | 1,200 |
| 2018/11/06 | 4,150 | 4,165 | 4,150 | 4,165 | -25 | -0.6% | 800 |
| 2018/11/05 | 4,220 | 4,255 | 4,190 | 4,190 | -30 | -0.7% | 1,200 |
| 2018/11/02 | 4,255 | 4,260 | 4,190 | 4,220 | -10 | -0.2% | 2,100 |
| 2018/11/01 | 4,230 | 4,230 | 4,230 | 4,230 | +70 | +1.7% | 800 |
| 2018/10/31 | 4,155 | 4,160 | 4,000 | 4,160 | +5 | +0.1% | 1,700 |
| 2018/10/30 | 4,030 | 4,235 | 4,030 | 4,155 | +100 | +2.5% | 5,400 |
| 2018/10/29 | 4,050 | 4,085 | 4,030 | 4,055 | -40 | -1% | 1,500 |
| 2018/10/26 | 4,240 | 4,240 | 4,095 | 4,095 | +60 | +1.5% | 3,400 |
| 2018/10/25 | 4,210 | 4,215 | 4,035 | 4,035 | -245 | -5.7% | 3,300 |
| 2018/10/24 | 4,220 | 4,295 | 4,200 | 4,280 | +130 | +3.1% | 2,300 |
| 2018/10/23 | 4,320 | 4,320 | 4,150 | 4,150 | -200 | -4.6% | 3,300 |
| 2018/10/22 | 4,355 | 4,355 | 4,285 | 4,350 | -55 | -1.2% | 3,700 |
| 2018/10/19 | 4,325 | 4,405 | 4,305 | 4,405 | +10 | +0.2% | 1,700 |
| 2018/10/18 | 4,400 | 4,405 | 4,380 | 4,395 | -5 | -0.1% | 1,700 |
| 2018/10/17 | 4,400 | 4,410 | 4,305 | 4,400 | +5 | +0.1% | 3,900 |
| 2018/10/16 | 4,390 | 4,395 | 4,365 | 4,395 | -15 | -0.3% | 3,000 |
| 2018/10/15 | 4,435 | 4,485 | 4,410 | 4,410 | -40 | -0.9% | 3,600 |
| 2018/10/12 | 4,475 | 4,545 | 4,450 | 4,450 | -165 | -3.6% | 4,300 |
| 2018/10/11 | 4,575 | 4,645 | 4,575 | 4,615 | -105 | -2.2% | 1,800 |
| 2018/10/10 | 4,725 | 4,790 | 4,720 | 4,720 | +65 | +1.4% | 1,100 |
| 2018/10/09 | 4,825 | 4,825 | 4,645 | 4,655 | -155 | -3.2% | 1,500 |
| 2018/10/05 | 4,830 | 4,840 | 4,700 | 4,810 | -30 | -0.6% | 4,500 |
| 2018/10/04 | 4,580 | 4,845 | 4,560 | 4,840 | +265 | +5.8% | 3,900 |
| 2018/10/03 | 4,590 | 4,690 | 4,575 | 4,575 | -20 | -0.4% | 2,300 |
| 2018/10/02 | 4,705 | 4,705 | 4,595 | 4,595 | +20 | +0.4% | 700 |
| 2018/10/01 | 4,590 | 4,590 | 4,570 | 4,575 | -85 | -1.8% | 2,200 |
| 2018/09/28 | 4,760 | 4,760 | 4,650 | 4,660 | -85 | -1.8% | 1,400 |
1601～
1650
件表示中 / 3735件
類似銘柄と比較する
現在ご覧いただいている「日ケミファ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日ケミファ | 151,600円 | +7.5% | -77.4% | 3.30% | 36.47倍 | 0.29倍 |
|
後発薬中堅、検査薬事業が第２の柱に。提携含めた新薬開発、ベトナムなど海外事業を中期強化 |
| ノイルイミューン | 17,100円 | -28.6% | - | 0.00% | - | 1.57倍 |
|
独自技術用いたＣＡＲ－Ｔ細胞免疫療法で抗がん剤を複数開発中。中外製薬とライセンス契約 |
| ティムス | 16,000円 | - | - | 0.00% | - | 2.57倍 |
|
東京農工大発創薬ベンチャー。黒カビ由来の急性期脳梗塞薬候補を中国ＣＯＲＸＥＬ社に導出 |
| モダリス | 8,100円 | - | - | 0.00% | - | 1.77倍 |
|
遺伝子治療薬の創薬ベンチャー、ＤＮＡ切断しないエピゲノム編集に強み。研究開発中心は米国 |
| カルナバイオ | 32,500円 | +13.5% | - | 0.00% | - | 2.51倍 |
|
キナーゼタンパク質の販売や受託試験など創薬初期の支援事業が柱。キナーゼ阻害剤で創薬も |
市場注目の銘柄
チャート関連のコラム
